Showing results (91-100 of 204) with videos related to

Sort By:
Pageof 21
Anticancer Research|December 31, 2021
Pre-operative Carboplatin/Paclitaxel Versus 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal CancerMohammed Al-Jumayli, Khalil Choucair, Ammar Al-Obaidi, et al.
Cancer Management and Research|December 28, 2018
The positive feedback loop between ILF3 and lncRNA ILF3-AS1 promotes melanoma proliferation, migration, and invasionGuozhen Gao, Wenjun Li, Sha Liu, et al.
American Journal of Translational Research|January 27, 2017
Long noncoding RNA MHENCR promotes melanoma progression via regulating miR-425/489-mediated PI3K-Akt pathwayXiangjun Chen, Hao Dong, Sha Liu, et al.
Pain Management Nursing : Official Journal of the American Society of Pain Management Nurses|July 17, 2026
Non-Pharmacological Interventions for Postoperative Pain in Breast Cancer Patients: A Network Meta-analysisYuanyuan Wang, Jiawei Song, Huiling Zhang, et al.
Journal of the National Cancer Institute|August 8, 2002
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancerA David McCollum, Paul J Catalano, Daniel G Haller, et al.
Gastrointestinal Cancer Research : GCR|March 6, 2009
Adjuvant Therapy for Stage II and III Colon Cancer: Consensus Report of the International Society of Gastrointestinal OncologyJohn L Marshall, Daniel G Haller, Aimery de Gramont, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2003
Impact of diabetes mellitus on outcomes in patients with colon cancerJeffrey A Meyerhardt, Paul J Catalano, Daniel G Haller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089Daniel G Haller, Paul J Catalano, John S Macdonald, et al.
Pageof 21